LFAS
Level Four Advisory Services’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $993K | Buy |
9,249
+89
| +1% | +$9.56K | 0.04% | 383 |
|
|
2025
Q1 | $924K | Buy |
9,160
+731
| +9% | +$73.7K | 0.04% | 363 |
|
|
2024
Q4 | $753K | Buy |
8,429
+761
| +10% | +$68K | 0.03% | 412 |
|
|
2024
Q3 | $644K | Buy |
7,668
+27
| +0.4% | +$2.27K | 0.03% | 452 |
|
|
2024
Q2 | $588K | Buy |
7,641
+2,474
| +48% | +$191K | 0.03% | 451 |
|
|
2024
Q1 | $299K | Hold |
5,167
| – | – | 0.02% | 612 |
|
|
2023
Q4 | $299K | Sell |
5,167
-442
| -8% | -$25.6K | 0.02% | 610 |
|
|
2023
Q3 | $296K | Hold |
5,609
| – | – | 0.02% | 580 |
|
|
2023
Q2 | $303K | Buy |
5,609
+125
| +2% | +$6.76K | 0.02% | 615 |
|
|
2023
Q1 | $274K | Buy |
5,484
+308
| +6% | +$15.4K | 0.02% | 606 |
|
|
2022
Q4 | $239K | Buy |
+5,176
| New | +$239K | 0.02% | 575 |
|
|
2022
Q2 | – | Sell |
-4,528
| Closed | -$201K | – | 572 |
|
|
2022
Q1 | $201K | Sell |
4,528
-896
| -17% | -$39.8K | 0.02% | 608 |
|
|
2021
Q4 | $230K | Buy |
+5,424
| New | +$230K | 0.02% | 574 |
|
|
2020
Q1 | – | Sell |
-4,452
| Closed | -$202K | – | 491 |
|
|
2019
Q4 | $202K | Buy |
+4,452
| New | +$202K | 0.01% | 545 |
|